Stacey B. Prenner, MD

faculty photo
Assistant Professor of Clinical Medicine
Department: Medicine

Contact information
3400 Civic Center Boulevard
744 Perelman Center for Advanced Medicine
South Pavillion
Philadelphia, PA 19104
Office: 215-349-8222
Education:
Diploma (High School)
Upper Dublin High School, 2003.
BS (Neuroscience and Behavioral Biology)
Emory University, 2007.
MD (Medicine)
Drexel University College of Medicine, 2011.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Hepatocellular Carcinoma
Liver Transplantation
Fatty Liver Disease
Complications of Cirrhosis
Hepatitis C

Description of Research Expertise

Hepatocellular Carcinoma
Liver Transplantation
Hepatitis C

Selected Publications

Prenner S, Kulik L: Hepatocellular Carcinoma. Zakim and Boyer’s Hepatology. Sanyal, Terrault, and Lindor Elsevier (eds.). Elsevier, 7th Edition: 668-692, 2018.

Prenner S, VanWagner L, Flamm S, Salem R, Lewandowski R and Kulik L: Hepatocellular Carcinoma Decreases the Chance of Successful HCV Therapy with Direct-Acting Antiviral Agents. J Hepatol 66(6): 1173-1181, June 2017.

Prenner S, Levitsky J: Comprehensive Review on Colorectal Cancer and Transplant. Am J Transplant. Page: Epub Ahead of Print, May 2017.

Prenner S, Rinella M: Moderate Exercise for Nonalcholic Fatty Liver Disease. JAMA Intern Med 176(8): 1083-4, Aug 2016.

Prenner S, VanWagner L, Kulik L: Hepatocellular Carcinoma Decreases Chance of Successful HCV Therapy in the Current Era. American Transplant Congress, Boston, MA June 2016 Notes: Oral presentation.

Prenner S, Kulik L: HCC: Where Does HCV Therapy Play a Role? Current Hepatology Reports 15(1): 17-25, May 2016.

Prenner S, Ganger D: Risk Stratification and Pre Operative Evaluation of the Patient With Known or Suspected Liver Disease Clinical Liver Disease 7(5): 101-10, May 2016.

Prenner S, Barman P: Bariatric Surgery as Primary Treatment for NASH American Liver Foundation, Great Lakes Division, Academic Debates, Chicago, IL Mar 2016 Notes: Oral presentation.

Prenner S, Ganger D: LIRADS Criteria for HCC Webinar, American Liver Foundation, Great Lakes Division, Chicago, IL Oct 2015 Notes: Oral presentation.

Simons S, Forde KA, Li Y, Reddy KR, Bahirwani R: Cardiovascular Disease in Liver Transplant Candidates with NASH/Cryptogenic Cirrhosis Digestive Diseases Week, Orlando, FL May 2013 Notes: Poster presentation.

back to top
Last updated: 09/08/2017
The Trustees of the University of Pennsylvania